Evidence map›Paper›PMID 31550353›Full record

ArticleNeuro-oncology2020

Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.

Niels Verburg, Thomas Koopman, Maqsood M Yaqub, Otto S Hoekstra, Adriaan A Lammertsma, Frederik Barkhof, Petra J W Pouwels, Jaap C Reijneveld, Jan J Heimans, Annemarie J M Rozemuller and 6 more

Abstract read
In one paragraph

Article in Neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Clinical potential of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Comparison ofClinical and translational radiation oncology · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Precision Surgery for Glioblastomas.Journal of personalized medicine · 2025
    Review
  17. Review
  18. Contribution of [Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Niels VerburgBrain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Thomas KoopmanDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Maqsood M YaqubDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Otto S HoekstraDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Adriaan A LammertsmaDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Petra J W PouwelsDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Jaap C ReijneveldBrain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Jan J HeimansDepartment of Neurology, Amsterdam UMC, VUmc, Amsterdam, Netherlands.
Annemarie J M RozemullerDepartment of Pathology, Amsterdam UMC, VUmc, Amsterdam, Netherlands.
Anne M E BruynzeelDepartment of Radiotherapy, Amsterdam UMC, VUmc, Amsterdam, Netherlands.
Frank LagerwaardDepartment of Radiotherapy, Amsterdam UMC, VUmc, Amsterdam, Netherlands.
William P VandertopBrain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Ronald BoellaardDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, location Free University Medical Center (VUmc), Amsterdam, Netherlands.
Pieter WesselingBrain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Philip C de Witt HamerBrain Tumor Center Amsterdam, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical resection and irradiation of diffuse glioma are guided by standard MRI: T2/fluid attenuated inversion recovery (FLAIR)-weighted MRI for non-enhancing and T1-weighted gadolinium-enhanced (T1G) MRI for enhancing gliomas. Amino acid PET has been suggested as the new standard. Imaging combinations may improve standard MRI and amino acid PET. The aim of the study was to determine the accuracy of imaging combinations to detect glioma infiltration.

methodsWe included 20 consecutive adults with newly diagnosed non-enhancing glioma (7 diffuse astrocytomas, isocitrate dehydrogenase [IDH] mutant; 1 oligodendroglioma, IDH mutant and 1p/19q codeleted; 1 glioblastoma IDH wildtype) or enhancing glioma (glioblastoma, 9 IDH wildtype and 2 IDH mutant). Standardized preoperative imaging (T1-, T2-, FLAIR-weighted, and T1G MRI, perfusion and diffusion MRI, MR spectroscopy and O-(2-[18F]-fluoroethyl)-L-tyrosine ([18F]FET) PET) was co-localized with multiregion stereotactic biopsies preceding resection. Tumor presence in the biopsies was assessed by 2 neuropathologists. Diagnostic accuracy was determined using receiver operating characteristic analysis.

resultsA total of 174 biopsies were obtained (63 from 9 non-enhancing and 111 from 11 enhancing gliomas), of which 129 contained tumor (50 from non-enhancing and 79 from enhancing gliomas). In enhancing gliomas, the combination of apparent diffusion coefficient (ADC) with [18F]FET PET (area under the curve [AUC], 95% CI: 0.89, 0.79‒0.99) detected tumor better than T1G MRI (0.56, 0.39‒0.72; P < 0.001) and [18F]FET PET (0.76, 0.66‒0.86; P = 0.001). In non-enhancing gliomas, no imaging combination detected tumor significantly better than standard MRI. FLAIR-weighted MRI had an AUC of 0.81 (0.65-0.98) compared with 0.69 (0.56-0.81; P = 0.019) for [18F]FET PET.

conclusionCombining ADC and [18F]FET PET detects glioma infiltration better than standard MRI and [18F]FET PET in enhancing gliomas, potentially enabling better guidance of local therapy.

Indexed as

AdultAgedBrainBrain NeoplasmsFemaleGliomaHumansMagnetic Resonance ImagingMaleMiddle AgedPositron-Emission TomographySensitivity and SpecificityYoung Adultbraingliomamagnetic resonance imagingpositron-emission tomographyROC curve

Identifiers

PMID31550353
PMCPMC7058442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.